Total Funding
60
44
Total FundingSeries A raised
Growth Score
-3 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
53280
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
- John Lu: President & CEO
- Allen Feng: Founder and Chief Scientific Officer
About the Company
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases the company's mission is to contribute to the fields of regenerative medicine and immuno-oncology by developing cell-based therapeutics. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a
bioreactor, allowing them to reproduce indefinitely.
